Skip to main content
C

COCHLEAR LIMITED — Investor Relations & Filings

Ticker · COH ISIN · AU000000COH5 LEI · 5493001OLLWY8KV5UC08 ASX Manufacturing
Filings indexed 1,424 across all filing types
Latest filing 2015-08-10 Regulatory Filings
Country AU Australia
Listing ASX COH

About COCHLEAR LIMITED

https://www.cochlear.com

Cochlear Limited designs, manufactures, and distributes implantable hearing solutions for individuals with moderate to profound hearing loss. The product suite includes cochlear implants, bone conduction systems, and acoustic implants, notably the Nucleus and Baha product lines. These technologies are engineered to bypass damaged parts of the ear to provide direct stimulation to the hearing nerve or bone. The company emphasizes research and development to advance sound processing capabilities, wireless integration, and miniaturization of components. Serving a global demographic from pediatric to geriatric patients, the organization provides long-term support and upgrades for its systems. Its focus remains on delivering high-performance hearing outcomes and enhancing the communication abilities of its recipients through technological innovation and clinical collaboration.

Recent filings

Filing Released Lang Actions
Full Year Statutory Accounts and Annual Report 126 pages 2.8MB
Regulatory Filings
2015-08-10 English
COH Full Year Results Analyst Presentation 11.08.2015 16 pages 858.0KB
Regulatory Filings
2015-08-10 English
Updated Trading Policy 19 pages 112.4KB
Regulatory Filings
2015-06-29 English
COH Chris Smith Announced as Incoming CEO of Cochlear 2 pages 33.8KB
Regulatory Filings
2015-05-25 English
Judgment in United States Patent Infringement Lawsuit 1
Regulatory Filings
2015-04-20 English
DECISION IN US PATENT INFRINGEMENT CASE 1 page 1.2M
Regulatory Filings
2015-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.